您的位置:
首页
>
农业专利
>
详情页
method for producing fatty acid esters, and, composition
- 专利权人:
- SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V.
- 发明人:
- Joseph James Alishusky,Paul Richard Weider,Pen-Chung Wang,Robert Lawrence Blackbourn
- 申请号:
- BR112015031937
- 公开号:
- BR112015031937A2
- 申请日:
- 2014.06.23
- 申请国别(地区):
- BR
- 年份:
- 2017
- 代理人:
- 摘要:
- 1/1 summary “method for producing fatty acid esters, and composition” is a method of producing fatty acid esters from in situ Microbial biomass such as algae are provided by treating the microbial biomass with a solution containing an alcohol and at least one Î ± -hydroxysulfonic acid. The fatty acid ester can be directly recovered from the treated microbial biomass. Î ± - hydroxysulfonic acid can be easily removed from treated and recycled microbial biomass.1 / 1 resumo “mã‰todo para produzir ã‰steres de ã�cido graxo, e, composiã‡ãƒoâ€� um mã©todo de produã§ã£o de ã©steres de ã¡cido graxo in situ a partir de biomassa microbiana, tais como algas sã£o providas pelo tratamento da biomassa microbiana com uma soluã§ã£o contendo um ã¡lcool e pelo menos um ã¡cido î±-hidroxisulfã´nico. ã‰ster de ã¡cido graxo pode ser diretamente recuperado a partir da biomassa microbiana tratada. o ã¡cido î±- hidroxisulfã´nico pode ser facilmente removido a partir da biomassa microbiana tratada e reciclada.
- 来源网站:
- 中国工程科技知识中心
- 来源网址:
- http://www.ckcest.cn/home/
相关专利
- COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF T-CELL EXHAUSTION USING CD39 BIOMARKERS AND MODULATORS
- COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF T-CELL EXHAUSTION USING CD39 BIOMARKERS AND MODULATORS
- Compositions and methods for identification, assessment, prevention, and treatment of T-cell exhaustion using CD39 biomarkers and modulators
- COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF T-CELL EXHAUSTION USING CD39 BIOMARKERS AND MODULATORS
- COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF T-CELL EXHAUSTION USING CD39 BIOMARKERS AND MODULATORS